IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 81 - 100 of 1100 stories.
February 27, 2014
Private equity firm H.I.G. Capital (Miami) says it has closed its $392-million acquisition of American Pacific (Ampac; Las Vegas) for $46.50/share, which was announced in January. Some...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/H-I-G-Capital-closes-Ampac-deal_59154.html
February 26, 2014
Ranbaxy Laboratories (Gurgaon, India) says that it has temporarily suspended shipping active pharmaceutical ingredients (APIs) produced at its plants at Toansa and Dewas, India. The...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Ranbaxy-stops-API-shipments-from-Indian-plants_59112.html
February 25, 2014
Mitsubishi Chemical to consolidate several health-care businesses under new company, Life Science Institute Mitsubishi Chemical Holdings, the parent of Mitsubishi Chemical, says that...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-25-February-2014_59060.html
February 21, 2014
Chemie Uetikon (Lahr, Germany) says that it acquired the entire business and product portfolio of amino acid building blocks from CordenPharma Switzerland, an active pharmaceutical...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Chemie-Uetikon-acquires-amino-acid-building-blocks-business-in-Switzerland-from-CordenPharma_59019.html
February 20, 2014
Merck KGaA says that Simon Sturge will join the company from Boehringer Ingelheim (Ingelheim, Germany) effective 1 March 2014, to head the biosimilars unit. The Simon Sturge...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Merck-KGaA-appoints-Simon-Sturge-as-new-head-of-biosimilars-unit_58935.html
February 19, 2014
Excipact says that Saudi Kayan Petrochemical (Al Jubail), an affiliate of Sabic, has received an Excipact certification from SGS, one of its certification bodies. The Excipact...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Saudi-Kayan-gets-Excipact-certification-as-pharmaceutical-excipient-supplier_58893.html
February 18, 2014
Aurobindo Pharma reports rise in API sales The active pharmaceutical ingredient (API) business of Aurobindo Pharma (Hyderabad, India) reports a 12.7% rise in sales in the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-18-February-2014_58865.html
February 17, 2014
Novartis announced today that it is buying CoStim Pharmaceuticals (Cambridge, MA), a privately held biotechnology company focused on harnessing the immune system to eliminate...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Novartis-to-acquire-biotech-company-CoStim-Pharmaceuticals_58852.html
February 12, 2014
Cedarburg Hauser Pharmaceuticals (CHP; Grafton, WI), a contract development and manufacturing organization specializing in small molecule active pharmaceutical ingredients (APIs), says...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/API-firm-Cedarburg-Hauser-appoints-director-of-process-development_58771.html
February 12, 2014
The active pharmaceutical ingredient (API) business of Aurobindo Pharma (Hyderabad, India) reports a 12.7% rise in sales in the company’s fiscal third quarter, ended 31 December...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Aurobindo-Pharma-reports-rise-in-API-sales_58768.html
February 11, 2014
The pharmaceutical services and active ingredients (PSAI) business of Dr. Reddy’s Laboratories (Hyderabad, India) reports a 29% fall in sales in the company’s fiscal third...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/API-business-of-Dr-Reddys-reports-fall-in-sales_58734.html
February 11, 2014
Cambrex (East Rutherford, NJ) reports a 79.6% fall in net profits for the fourth quarter of 2013, ended 31 December, compared with the year-ago quarter, to $8.89 million. The results...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambrex-reports-fall-in-profits_58732.html
February 11, 2014
Jazz Pharmaceuticals (Dublin), a specialty biopharmaceutical company, on Monday held a ground breaking ceremony for a €45–50 million ($60-68 million) manufacturing and...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Jazz-Pharmaceuticals-builds-$60-million-manufacturing-and-development-plant-in-Ireland_58731.html
February 11, 2014
Teva’s API business reports fall in sales The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (Petaḥ Tiqwa, Israel) reports a 19.3% fall in...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-11-February-2014_58730.html
February 7, 2014
The active pharmaceutical ingredient (API) business of Ranbaxy Laboratories (Gurgaon, India) reports sales of 1.37 billion Indian rupees ($22 million) in the fourth quarter of 2013...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Ranbaxys-API-sales-fall-on-lower-demand_58659.html
February 7, 2014
The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (Petaḥ Tiqwa, Israel) reports a 19.3% fall in sales in the fourth quarter of 2013, compared with...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Tevas-API-business-reports-fall-in-sales_58658.html
February 5, 2014
FMC today reported fourth-quarter earnings down 73.5% year-on-year (YOY), to $27.1 million, or 20 cts/share, on sales up 24%, to $1.1 billion. Earnings were hit by $114.3 million in...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FMC-earnings-beat-estimates-as-ag-results-jump_58582.html
February 4, 2014
Johnson Matthey appoints new CEO, fine chemicals sales up Johnson Matthey announced the appointment of its new CEO and reported the third-quarter results, covering 1 October 2013...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-4-February-2014_58536.html
January 28, 2014
Albemarle today reported fourth-quarter adjusted earnings of $88.4 million, or $1.08/share, down 16% year-on-year (YOY), but ahead of analysts' consensus estimate of $1.04/share as...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Albemarle-earnings-fall-YOY-but-beat-estimates_58379.html
Pages: « Previous  1 2 3 4 [5] 6 7 8 9 10 11 12 13 14 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa